Drug Shortage Report for RIXUBIS
| Report ID | 198631 |
| Drug Identification Number | 02431947 |
| Brand name | RIXUBIS |
| Common or Proper name | Recombinant Coagulation Factor IX (rFIX) |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NONACOG GAMMA |
| Strength(s) | 1000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 mL Vial |
| ATC code | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-07-13 |
| Actual start date | 2023-07-13 |
| Estimated end date | 2023-08-31 |
| Actual end date | 2023-08-28 |
| Shortage status | Resolved |
| Updated date | 2023-08-28 |
| Company comments | Possible complaints on BAXJECT II Transfer Device co-packaged with RIXUBIS drug product |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-08-28 | French | Compare |
| v4 | 2023-08-28 | English | Compare |
| v3 | 2023-07-14 | English | Compare |
| v2 | 2023-07-13 | French | Compare |
| v1 | 2023-07-13 | English | Compare |
Showing 1 to 5 of 5